Podium presentation will include clinical updates from the Company's Phase 2 clinical trials investigating azeliragon, in combination with radiation therapy with or without temozolomide, in newly diagnosed glioblastoma WESTON, Fla. , March 19, 2024 /PRNewswire/ -- Cantex Pharmaceuticals , Inc. , a clinical stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening... Read More